Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
3102 ARTÍCULOS , VIENDO DEL 1561 AL 1575
N-[(18)F]Fluoroethylpiperidin-4ylmethyl acetate
Leung K.
2010 Mar 17 [updated 2010 Sep 23]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.
Predicting acute affective symptoms after deep brain stimulation surgery in Parkinson's disease
Schneider F, Reske M, Finkelmeyer A, Wojtecki L, Timmermann L, Brosig T, Backes V, Amir-Manavi A, Sturm V, Habel U, Schnitzler A.
Stereotact Funct Neurosurg. 2010;88(6):367-73. doi: 10.1159/000319046. Epub 2010 Sep 22.
Safarinejad MR, Taghva A, Shekarchi B, Safarinejad Sh.
Int J Impot Res. 2010 Sep-Oct;22(5):325-35. doi: 10.1038/ijir.2010.23. Epub 2010 Sep 23.
The physical, social and emotional effects of bowel dysfunction in Parkinson's disease
Kyle G.
Nurs Times. 2010 Aug 24-30;106(33):20-2.
Development and testing of a self administered version of the Freezing of Gait Questionnaire
Nilsson MH, Hariz GM, Wictorin K, Miller M, Forsgren L, Hagell P.
BMC Neurol. 2010 Sep 23;10:85. doi: 10.1186/1471-2377-10-85.
Validation of diagnostic criteria for apathy in Parkinson's disease
Drijgers RL, Dujardin K, Reijnders JS, Defebvre L, Leentjens AF.
Parkinsonism Relat Disord. 2010 Dec;16(10):656-60. doi: 10.1016/j.parkreldis.2010.08.015. Epub 2010 Sep 22.
Understanding graft-induced dyskinesia
Lane EL, Smith GA.
Regen Med. 2010 Sep;5(5):787-97. doi: 10.2217/rme.10.42.
The glutathione system and its regulation by neurohormone melatonin in the central nervous system
Limón-Pacheco JH, Gonsebatt ME.
Cent Nerv Syst Agents Med Chem. 2010 Dec 1;10(4):287-97. doi: 10.2174/187152410793429683.
Biomarkers of cell damage induced by oxidative stress in Parkinson's disease and related models
Tobón-Velasco JC, Carmona-Aparicio L, Ali SF, Santamaría A.
Cent Nerv Syst Agents Med Chem. 2010 Dec 1;10(4):278-86. doi: 10.2174/187152410793429719.
Parkinson's disease and other movement disorders
Chen JJ.
Am J Geriatr Pharmacother. 2010 Aug;8(4):293. doi: 10.1016/j.amjopharm.2010.08.005.
Clinical review of treatment options for select nonmotor symptoms of Parkinson's disease
Wood LD, Neumiller JJ, Setter SM, Dobbins EK.
Am J Geriatr Pharmacother. 2010 Aug;8(4):294-315. doi: 10.1016/j.amjopharm.2010.08.002.
Management of hallucinations and psychosis in Parkinson's disease
Eng ML, Welty TE.
Am J Geriatr Pharmacother. 2010 Aug;8(4):316-30. doi: 10.1016/j.amjopharm.2010.08.004.
Applications and bioefficacy of the functional food supplement fermented papaya preparation
Aruoma OI, Hayashi Y, Marotta F, Mantello P, Rachmilewitz E, Montagnier L.
Toxicology. 2010 Nov 28;278(1):6-16. doi: 10.1016/j.tox.2010.09.006. Epub 2010 Sep 24.
[A new form of cell death: Parthanatos]
Wang LB, Zhang LY, Shan CH.
Yi Chuan. 2010 Sep;32(9):881-5. doi: 10.3724/sp.j.1005.2010.01187.
Transcranial direct current stimulation for the treatment of Parkinson's disease
Benninger DH, Lomarev M, Lopez G, Wassermann EM, Li X, Considine E, Hallett M.
J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1105-11. doi: 10.1136/jnnp.2009.202556.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.